# A Clinical Study Preliminary Efficacy of LM-061 Tablet in Subjects With Advanced Tumours

> **NCT04882176** · PHASE1,PHASE2 · TERMINATED · sponsor: **LaNova Medicines Limited** · enrollment: 18 (actual)

## Conditions studied

- Advanced Tumours

## Interventions

- **DRUG:** LM-061

## Key facts

- **NCT ID:** NCT04882176
- **Lead sponsor:** LaNova Medicines Limited
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2021-05-20
- **Primary completion:** 2023-02-07
- **Final completion:** 2023-07-19
- **Target enrollment:** 18 (ACTUAL)
- **Why stopped:** Not meeting expected endpoints
- **Last updated:** 2023-07-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04882176

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04882176, "A Clinical Study Preliminary Efficacy of LM-061 Tablet in Subjects With Advanced Tumours". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT04882176. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*